Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03839342
Title Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations (BEAVER)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto
Indications

Advanced Solid Tumor

Therapies

Binimetinib + Encorafenib

Age Groups: senior | adult
Covered Countries CAN

Additional content available in CKB BOOST